Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
Jonathan Gutman
Study ID
Protocol Number: 23-0111
More information available at ClinicalTrials.gov: NCT05346835
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers